Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Fish and Richardson
McKinsey
UBS
Chubb
Dow
Express Scripts
Accenture
Fuji
Deloitte

Generated: January 20, 2018

DrugPatentWatch Database Preview

TRINALIN Drug Profile

« Back to Dashboard

When do Trinalin patents expire, and when can generic versions of Trinalin launch?

Trinalin is a drug marketed by Schering and is included in one NDA.

The generic ingredient in TRINALIN is azatadine maleate; pseudoephedrine sulfate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate; pseudoephedrine sulfate profile page.
Summary for TRINALIN
Drug patent expirations by year for TRINALIN

US Patents and Regulatory Information for TRINALIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering TRINALIN azatadine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 018506-001 Mar 23, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TRINALIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering TRINALIN azatadine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 018506-001 Mar 23, 1982 ➤ Subscribe ➤ Subscribe
Schering TRINALIN azatadine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 018506-001 Mar 23, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Healthtrust
US Army
QuintilesIMS
Express Scripts
Citi
Fuji
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot